Form4insider filings, from the source

SEC Form 4 · accession 0001012975-17-000654

Altimmune, Inc. · ALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 21, 2017
Accepted (ET)
Aug 23, 2017 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001F1Aug 21, 2017P690$2.0213A105,068D
Common Stock, par value $0.0001F2Aug 22, 2017P5,958$2.1012A111,026D
Common Stock, par value $0.0001F3Aug 23, 2017P43,352$2.2225A154,378D
Common Stock, par value $0.0001holding———12,393IIRA

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses